Background and Rationale People living with HIV have a greatly increased risk of developing tuberculosis (TB). In 2014, it was estimated that TB caused the death of 400,000 people living with HIV, accounting for one in four HIV-related deaths worldwide.1 A critical, but often underutilized medication that prevents TB among people living with HIV is … Continue reading The ENRICH Study: Evaluating an Innovative Approach to Increasing Use of Isoniazid Preventive Therapy to Prevent TB among People Living with HIV